H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.
H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.
复制标题
H-RN 是一种源自肝细胞生长因子的肽,通过诱导内皮细胞凋亡和阻止细胞周期来抑制角膜新生血管形成
DOI:
10.1186/1471-2121-14-8
复制
发表时间:
2013-02-24
期刊:
影响因子:
--
通讯作者:
Xu X
中科院分区:
文献类型:
--
作者:
Sun Y;Su L;Wang Z;Xu Y;Xu X
BackgroundThe goal of this study was to investigate the anti-angiogenic activity of a novel peptide H-RN, derived from the hepatocyte growth factor kringle 1 domain (HGF K1), in a mouse model of corneal neovascularization. The anti-angiogenic effect of H-RN on vascular endothelial growth factor (VEGF)-stimulated cell proliferation, cell migration and endothelial cell tube formation was assessedin vitrousing Human Umbilical Vein Endothelial Cells (HUVECs) andin vivousing a mouse cornea micropocket assay. Apoptosis and cell cycle arrest were assessed by flow cytometry. A scrambled peptide was used as a negative control.ResultsH-RN effectively inhibited VEGF-stimulated HUVEC proliferation, migration and tube formation on Matrigel, while a scrambled peptide exerted no effect. In the mouse model of corneal angiogenesis, VEGF-stimulated angiogenesis was significantly inhibited by H-RN compared to a scrambled peptide that had no such activity. VEGF protected HUVECs from apoptosis, while H-RN inhibited this protective effect of VEGF. VEGF significantly increased the proportion of cells in the S phase compared to control treated cells (p<0.05). Treatment with H-RN (1.5 mM) induced the accumulation of cells in G0/G1 phase, while the proportion of cells in the S phase and G2/M phase decreased significantly compared to control group (p<0.05).ConclusionsH-RN has anti-angiogenic activity in HUVECs and in a mouse model of VEGF-induced corneal neovascularization. The anti-angiogenic activity of H-RN was related to apoptosis and cell cycle arrest, indicating a potential strategy for anti-angiogenic treatment in the cornea.
登录
查看更多内容
DOI:
10.1016/j.bbrc.2010.11.122
发表时间:
2011-01-07
影响因子:
3.1
作者:
Li, Jianqiao;Chen, Xiaoyun;Luo, Yan
通讯作者:
Luo, Yan
DOI:
10.1007/s00417-011-1760-3
发表时间:
2011-11-01
影响因子:
2.7
作者:
Han, Eui Seok;Wee, Won Ryang;Kim, Mee Kum
通讯作者:
Kim, Mee Kum
影响因子:
10.8
作者:
Mu, H;Ohashi, R;Chen, CY
通讯作者:
Chen, CY
影响因子:
--
作者:
Dastjerdi, Mohammad H.;Al-Arfaj, Khalid M.;Nallasamy, Nambi;Hamrah, Pedram;Jurkunas, Ula V.;Pineda, Roberto, II;Pavan-Langston, Deborah;Dana, Reza
通讯作者:
Dana, Reza
影响因子:
6.1
作者:
Chen, Jeff Yi-Fu;Hwang, Chi-Ching;Chiu, Chien-Chih
通讯作者:
Chiu, Chien-Chih